Severe non-atopic asthma: omalizumab can reduce severe asthma exacerbations

Taylor and Francis Group, Journal of Asthma, 5(60), p. 881-889, 2022

Journal article published in 2022 by Lise Melscoet

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by